Table 2. Diagnostic accuracy of 2D SWE and VCTE for the diagnosis of fibrosis stage.
≥F1 (95% CI) | ≥F2 (95% CI) | ≥F3 (95% CI) | F4 (95% CI) | |||||
---|---|---|---|---|---|---|---|---|
2D SWE | VCTE | 2D SWE | VCTE | 2D SWE | VCTE | 2D SWE | VCTE | |
AUROC | 0.815 (0.760–0.869) | 0.777 (0.689–0.875) | 0.870 (0.823–0.917) | 0.837 (0.789–0.925) | 0.910 (0.872–0.948) | 0.897 (0.805–0.968) | 0.933 (0.892–0.974) | 0.923 (0.863–0.987) |
Cut-off value | 6.430 | 7.672 | 7.250 | 9.921 | 8.409 | 11.892 | 10.047 | 14.864 |
Sensitivity | 0.832 (0.758–0.887) | 0.595 (0.510–0.675) | 0.874 (0.785–0.929) | 0.649 (0.564–0.725) | 0.875 (0.760–0.940) | 0.893 (0.781–0.953) | 0.889 (0.709–0.968) | 0.926 (0.753–0.989) |
Specificity | 0.659 (0.557–0.748) | 0.791 (0.696–0.862) | 0.689 (0.606–0.761) | 0.747 (0.648–0.825) | 0.759 (0.688–0.818) | 0.745 (0.663–0.796) | 0.826 (0.766–0.873) | 0.734 (0.678–0.800) |
PPV | 0.779 (0.710–0.847) | 0.804 (0.725–0.883) | 0.644 (0.558–0.730) | 0.787 (0.710–0.864) | 0.551 (0.447–0.654) | 0.532 (0.431–0.633) | 0.414 (0.287–0.541) | 0.333 (0.227–0.440) |
NPV | 0.732 (0.636–0.828) | 0.576 (0.489–0.663) | 0.894 (0.835–0.953) | 0.596 (0.506–0.687) | 0.947 (0.909–0.985) | 0.953 (0.917–0.990) | 0.982 (0.961–1.000) | 0.986 (0.968–1.000) |
LR+ | 2.443 (1.817–3.284) | 2.852 (1.866–4.358) | 2.808 (2.158–3.654) | 2.567 (1.764–3.736) | 3.631 (2.724–4.841) | 3.369 (2.574–4.409) | 5.098 (3.653–7.114) | 3.611 (2.779–4.692) |
LR– | 0.255 (0.169–0.383) | 0.511 (0.405–0.646) | 0.184 (0.104–0.323) | 0.470 (0.362–0.610) | 0.165 (0.082–0.331) | 0.146 (0.068–0.312) | 0.135 (0.046–0.392) | 0.112 (0.026–0.379) |
2D SWE, two-dimensional shear wave elastography; AUROC, area under the receiver operating characteristic curve; CI: confidence interval; LR+, positive likelihood ratio; LR−, negative likelihood ratio; NPV, negative predictive value; PPV, positive predictive value; VCTE, vibration controlled transient elastography.